| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30002376 | HIV | ENSG00000172183.16 | protein_coding | ISG20 | No | No | 3669 | Q96AZ6 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ISG20 |
|---|---|
| DrugBank ID | DB03685 |
| Drug Name | Uridine monophosphate |
| Target ID | BE0001938 |
| UniProt ID | Q96AZ6 |
| Regulation Type | |
| PubMed IDs | 17139284; 17016423 |
| Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. |
| Groups | Experimental |
| Direct Classification | Pyrimidine ribonucleoside monophosphates |
| SMILES | O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O |
| Pathways | Clomocycline Action Pathway; Rolitetracycline Action Pathway; Dihydropyrimidinase Deficiency; Lactose Synthesis; Demeclocycline Action Pathway; Josamycin Action Pathway; Gentamicin Action Pathway; Kanamycin Action Pathway; Tobramycin Action Pathway; MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy); Azithromycin Action Pathway; Clarithromycin Action Pathway; beta-Ureidopropionase Deficiency; UMP Synthase Deficiency (Orotic Aciduria); Troleandomycin Action Pathway; Amikacin Action Pathway; Streptomycin Action Pathway; Pyrimidine Metabolism; Congenital Disorder of Glycosylation CDG-IId; Oxytetracycline Action Pathway; Tetracycline Action Pathway; Spectinomycin Action Pathway; Erythromycin Action Pathway; Netilmicin Action Pathway; Doxycycline Action Pathway; Telithromycin Action Pathway; Neomycin Action Pathway; Roxithromycin Action Pathway; Arbekacin Action Pathway; Clindamycin Action Pathway |
| PharmGKB | |
| ChEMBL | CHEMBL214393 |
